Biosimilar
A biologic product approved as highly similar to an FDA-approved reference biologic, with no clinically meaningful differences in safety, purity, or potency.
TL;DR
Real-world data helps organizations understand what happens in everyday care so they can make smarter, faster, and more impactful decisions.
CATEGORY
Data & Analytics
WHO IT IMPACTS
[Pharmaceutical & Life Sciences Companies, Payers, Providers, Health Systems, Patients]
DEFINITION
Should include:
• A formal, comprehensive, and authoritative explanation of the term.
• Key components, stakeholders, or elements that define it.
• Any important nuances, variations, or standards (e.g., regulatory, clinical, operational).
• Written in clear but more detailed language than the summary above.
WHY IT MATTERS
Should include:
• The significance of this term in healthcare today.
• How it impacts outcomes, costs, strategy, or decision-making.
• The benefits or value it creates for patients, providers, payers, or the industry.
• Why organizations should understand or pay attention to this concept.